ReviewSeminars in hematology2023

CD19 CAR-T cell therapy for relapsed or refractory diffuse large B cell lymphoma: Why does it fail?

Hannah Kinoshita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.